Lewy Body Dementia Specialist Sees Aricept Approval Modification as Positive Move

Kanagawa Dental University Professor Yuta Manabe A modification of the Japanese regulatory approval for Eisai’s Aricept (donepezil) to restrict its use in patients with dementia with Lewy bodies (DLB) is a positive move that would promote the drug’s proper use,...read more